HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (13) Citing Articles via Google Scholar Google Scholar Articles by Helander, A. Articles by Bergström, J. P. Search for Related Content PubMed PubMed Citation Articles by Helander, A. Articles by Bergström, J. P. Related Collections Molecular Diagnostics and Genetics

Comparison of HPLC and Capillary Electrophoresis for Confirmatory Testing of the Alcohol Misuse Marker Carbohydrate-Deficient Transferrin

¹ Department of Clinical Neuroscience, Karolinska Institutet & University Hospital, Stockholm, Sweden;
² Department of Clinical Chemistry, Meander Medical Center, Amersfoort, The Netherlands;

^aaddress correspondence to this author at: Alcohol Laboratory, L7:03, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden; fax 46-8-51771532, e-mail Anders.Helander@cns.ki.se

The first 300 words of the full text of this article appear below.

The major form of the iron-transport glycoprotein transferrin in blood contains 2 N-linked disialylated biantennary oligosaccharide chains (glycans) and is named tetrasialotransferrin. Regular high alcohol consumption (mean of at least 50–80 g/day) generally alters the glycosylation profile of transferrin (1), increasing the relative amounts of glycoforms lacking one (disialotransferrin) or both (asialotransferrin) N-glycans (2)(3). The alcohol-related glycoforms are collectively referred to as carbohydrate-deficient transferrin (CDT). CDT measurements are widely used for identifying individuals with alcohol problems in various medical settings (e.g., addiction treatment) and for monitoring abstinence from alcohol in outpatient treatment programs (e.g., when drunk-driving offenders reapply for a driver’s license) (4). When drinking is discontinued, the CDT concentration normalizes with a half-life of 1.5–2 weeks (5)(6). The main advantage of CDT over the conventional alcohol biomarkers, such as the liver function test -glutamyltransferase, is the higher specificity for alcohol misuse with resulting lower risk for false-positive identifications (7)(8).

Since the discovery of CDT as an alcohol marker (1), a multitude of analytical techniques and methods have been applied for its measurement (1)(9). The most widely used assays worldwide today are the Axis-Shield %CDT immunoassay and various automated applications thereof, such as %CDT TIA from Bio-Rad and Tina-quant® %CDT from Roche (10)(11). These assays are based on ion-exchange minicolumn chromatographic isolation of the CDT fraction, separate measurement of CDT and total transferrin using the same transferrin antibody, and calculating CDT as a percentage of total transferrin (%CDT). Immunologic methods are convenient and time-efficient for routine use in central laboratories with high specimen throughput, but because these tests separate CDT from non-CDT moieties on the basis of differences in isoelectric point (pI), they will . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				F. Schellenberg, L. Mennetrey, C. Girre, B. Nalpas, and J. C. Pages Automated Measurement of Carbohydrate-Deficient Transferrin Using the Bio-Rad %CDT by the HPLC Test on a VariantTM HPLC System: Evaluation and Comparison with Other Routine Procedures Alcohol Alcohol., September 1, 2008; 43(5): 569 - 576. [Abstract] [Full Text] [PDF]

				J. R. Delanghe, A. Helander, J. P.M. Wielders, J. M. Pekelharing, H. J. Roth, F. Schellenberg, C. Born, E. Yagmur, W. Gentzer, and H. Althaus Development and Multicenter Evaluation of the N Latex CDT Direct Immunonephelometric Assay for Serum Carbohydrate-Deficient Transferrin Clin. Chem., June 1, 2007; 53(6): 1115 - 1121. [Abstract] [Full Text] [PDF]